Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphomas: Final Results from a Phase 1-2 Trial
Year: 2014
Type: article
Study design: Clinical Trial
Source: Blood
Institutions: Massachusetts General Hospital, Dana-Farber Cancer Institute
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2405898030
